MAPT and type 2 diabetes mellitus: We favour the view that neurodegenerative processes underlying T2DM’s pathophysiology might also leads to the presence of brain atrophy, where toxic glucose levels have a harmful impact on various biochemical processes associated with tau integrity, promoting tau cleavage and phosphorylation (Kubis-Kubiak et al., 2019; Huang et al., 2020).